Acumen Pharmaceuticals Inc (NASDAQ:ABOS)

6.18
Delayed Data
As of Nov 25
 -0.18 / -2.83%
Today’s Change
3.02
Today|||52-Week Range
10.97
-8.58%
Year-to-Date

Stock Price Forecast

The 5 analysts offering 12-month price forecasts for Acumen Pharmaceuticals Inc have a median target of 16.00, with a high estimate of 22.00 and a low estimate of 9.00. The median estimate represents a +158.90% increase from the last price of 6.18.

Analyst Recommendations

The current consensus among 5 polled investment analysts is to Buy stock in Acumen Pharmaceuticals Inc. This rating has held steady since November, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.27
Sales
$0.00
Reporting Date
Mar 27

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -3.89%
 
 
 
 
 
 
Growthannually 79.97%
 
 
 

Sales

Growthquarterly --
Growthannually --
Key to the earnings and sales forecast charts.